======= ZEB2 ======= == Gene Information == * **Official Symbol**: ZEB2 * **Official Name**: zinc finger E-box binding homeobox 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9839|9839]] * **UniProt**: [[https://www.uniprot.org/uniprot/O60315|O60315]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZEB2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZEB2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605802|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a member of the Zfh1 family of 2-handed zinc finger/homeodomain proteins. It is located in the nucleus and functions as a DNA-binding transcriptional repressor that interacts with activated SMADs. Mutations in this gene are associated with Hirschsprung disease/Mowat-Wilson syndrome. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jan 2010]. * **UniProt Summary**: Transcriptional inhibitor that binds to DNA sequence 5'- CACCT-3' in different promoters. Represses transcription of E- cadherin. {ECO:0000269|PubMed:16061479}. No Pfam Domain information is available for this gene. |positive regulation of lens fiber cell differentiation| |mammillary body development| |regulation of melanosome organization| |melanocyte migration| |mammillary axonal complex development| |regulation of lens fiber cell differentiation| |positive regulation of melanocyte differentiation| |positive regulation of melanin biosynthetic process| |regulation of melanocyte differentiation| |corpus callosum morphogenesis| |positive regulation of secondary metabolite biosynthetic process| |corticospinal tract morphogenesis| |positive regulation of pigment cell differentiation| |regulation of pigment cell differentiation| |phosphatase regulator activity| |collateral sprouting| |positive regulation of developmental pigmentation| |regulation of melanin biosynthetic process| |regulation of secondary metabolite biosynthetic process| |regulation of secondary metabolic process| |regulation of developmental pigmentation| |corpus callosum development| |R-SMAD binding| |central nervous system projection neuron axonogenesis| |cell proliferation in forebrain| |central nervous system neuron axonogenesis| |developmental pigmentation| |neural crest cell migration| |positive regulation of epithelial cell differentiation| |somitogenesis| |positive regulation of JUN kinase activity| |neural precursor cell proliferation| |diencephalon development| |neural crest cell development| |central nervous system neuron development| |hippocampus development| |somite development| |mesenchymal cell development| |epithelial cell migration| |stem cell development| |positive regulation of axonogenesis| |epithelium migration| |regulation of JUN kinase activity| |developmental cell growth| |neural crest cell differentiation| |cell growth| |neural tube closure| |tube closure| |pigmentation| |tissue migration| |segmentation| |primary neural tube formation| |neural tube formation| |limbic system development| |developmental growth involved in morphogenesis| |embryonic epithelial tube formation| |epithelial tube formation| |positive regulation of JNK cascade| |regulation of epithelial cell differentiation| |morphogenesis of embryonic epithelium| |tube formation| |positive regulation of cell morphogenesis involved in differentiation| |mesenchymal cell differentiation| |stem cell differentiation| |neural tube development| |positive regulation of stress-activated MAPK cascade| |positive regulation of stress-activated protein kinase signaling cascade| |ameboidal-type cell migration| |pallium development| |positive regulation of Wnt signaling pathway| |central nervous system neuron differentiation| |regulation of axonogenesis| |regulation of JNK cascade| |anterior/posterior pattern specification| |mesenchyme development| |regulation of stress-activated MAPK cascade| |regulation of stress-activated protein kinase signaling cascade| |nuclear chromatin| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |telencephalon development| |positive regulation of MAP kinase activity| |positive regulation of neuron projection development| |regulation of cell morphogenesis involved in differentiation| |epithelial tube morphogenesis| |regionalization| |positive regulation of protein serine/threonine kinase activity| |regulation of MAP kinase activity| |regulation of Wnt signaling pathway| |positive regulation of neuron differentiation| |axonogenesis| |positive regulation of cell projection organization| |forebrain development| |developmental growth| |growth| |axon development| |sequence-specific DNA binding| |cell morphogenesis involved in neuron differentiation| |morphogenesis of an epithelium| |pattern specification process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |positive regulation of neurogenesis| |neuron projection morphogenesis| |plasma membrane bounded cell projection morphogenesis| |regulation of cell morphogenesis| |cell projection morphogenesis| |regulation of neuron projection development| |cell part morphogenesis| |regulation of protein serine/threonine kinase activity| |positive regulation of protein kinase activity| |positive regulation of nervous system development| |positive regulation of cell development| |positive regulation of MAPK cascade| |cell population proliferation| |cell morphogenesis involved in differentiation| |tissue morphogenesis| |embryonic morphogenesis| |positive regulation of kinase activity| |chordate embryonic development| |embryo development ending in birth or egg hatching| |tube morphogenesis| |positive regulation of transferase activity| |regulation of neuron differentiation| |neuron projection development| |regulation of plasma membrane bounded cell projection organization| |regulation of cell projection organization| |cell morphogenesis| |regulation of cellular response to stress| |brain development| |regulation of MAPK cascade| |head development| |regulation of protein kinase activity| |neuron development| |regulation of neurogenesis| |cellular component morphogenesis| |tube development| |nucleolus| |negative regulation of transcription by RNA polymerase II| |regulation of kinase activity| |anatomical structure formation involved in morphogenesis| |regulation of nervous system development| |regulation of cell development| |cell migration| |positive regulation of cell differentiation| |regulation of transferase activity| |embryo development| |central nervous system development| |neuron differentiation| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |positive regulation of phosphorylation| |regulation of anatomical structure morphogenesis| |cell motility| |localization of cell| |epithelium development| |plasma membrane bounded cell projection organization| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |cell projection organization| |negative regulation of transcription, DNA-templated| |positive regulation of cellular component organization| |positive regulation of transcription by RNA polymerase II| |positive regulation of protein modification process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |regulation of organelle organization| |locomotion| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |positive regulation of catalytic activity| |negative regulation of nucleobase-containing compound metabolic process| |regulation of protein phosphorylation| |negative regulation of macromolecule biosynthetic process| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |generation of neurons| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |movement of cell or subcellular component| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |positive regulation of signal transduction| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-2.08| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|-2.06| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-1.92| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|-1.84| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|1.71| |[[:results:exp112|S-DABN 8μM R03 exp112]]|1.77| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|1.86| |[[:results:exp98|BI-6727 0.04μM R03 exp98]]|1.92| |[[:results:exp326|CCT251545 20μM R07 exp326]]|3.49| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 25/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|6/28| |bone|1/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|5/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1109 * **Expression level (log2 read counts)**: 7.33 {{:chemogenomics:nalm6 dist.png?nolink |}}